Australia's Imagion Biosystems rises on MOU for cancer detection device

Prestige Biopharma

11/08/2023 04:08

** Shares of Imagion Biosystems  IBX.AX  rise as much as
28.6% to A$0.018, their highest since July 21
    ** Stock set for best day since July 11, if gains hold
    ** The medical imaging company says it entered an agreement
with Prestige Biopharma  950210.KS  to develop an early
pancreatic cancer diagnosis platform
    ** Says the agreement covers preclinical feasibility
research
    ** Adds if research produce favorable results, both cos may
agree to expand collaboration to advance the technologies
    ** IBX stock down 41.7% YTD, as of last close
        
  

 (Reporting by Adwitiya Srivastava in Bengaluru)
 ((Adwitiya.Srivastava@thomsonreuters.com;))